Literature DB >> 7191771

Glucocorticoid receptors in human tumors.

S H Liu, M Otal-Brun, T E Webb.   

Abstract

Glucocorticoid receptors were examined in a range of solid human tumors. In addition to breast carcinomas, subsets of other tumor types (notably renal cell carcinomas) contain concentrations of these receptors characteristic of glucocorticoid-responsive tissues. The physico-chemical properties of the single glucocorticoid receptor present in the human tumors resembled those of the glucocorticoid receptor in rat tumors and the predominant form found in normal target tissues of the rat.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7191771     DOI: 10.1016/0304-3835(80)90080-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.

Authors:  Yen-Shen Lu; Huang-Chun Lien; Pei-Yen Yeh; Kun-Huei Yeh; Min-Liang Kuo; Sung-Hsin Kuo; Ann-Lii Cheng
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

2.  Glucocorticoid receptor (GR) immunohistochemical expression is correlated with cell cycle-related molecules in human colon cancer.

Authors:  Stamatios Theocharis; Gregorios Kouraklis; Alexandra Margeli; Emmanuel Agapitos; Sotirios Ninos; Gabriel Karatzas; Antonios Koutselinis
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

3.  Network Pharmacology-Based Approach to Investigate the Molecular Targets of Sinomenine for Treating Breast Cancer.

Authors:  Xiao-Mei Li; Mao-Ting Li; Ni Jiang; Ya-Chen Si; Meng-Mei Zhu; Qiao-Yuan Wu; Dong-Chen Shi; Hui Shi; Qing Luo; Bing Yu
Journal:  Cancer Manag Res       Date:  2021-02-09       Impact factor: 3.989

Review 4.  The glucocorticoid receptor signalling in breast cancer.

Authors:  Paraskevi Moutsatsou; Athanasios G Papavassiliou
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.